Avanos Medical (AVNS) Income towards Parent Company (2016 - 2024)
Historic Income towards Parent Company for Avanos Medical (AVNS) over the last 11 years, with Q3 2024 value amounting to -$1.6 million.
- Avanos Medical's Income towards Parent Company fell 13137.25% to -$1.6 million in Q3 2024 from the same period last year, while for Dec 2024 it was -$5.5 million, marking a year-over-year increase of 8940.27%. This contributed to the annual value of -$51.9 million for FY2023, which is 27896.55% down from last year.
- As of Q3 2024, Avanos Medical's Income towards Parent Company stood at -$1.6 million, which was down 13137.25% from -$2.5 million recorded in Q2 2024.
- Avanos Medical's Income towards Parent Company's 5-year high stood at $38.5 million during Q2 2021, with a 5-year trough of -$63.8 million in Q2 2023.
- Its 5-year average for Income towards Parent Company is -$4.9 million, with a median of -$500000.0 in 2023.
- Its Income towards Parent Company has fluctuated over the past 5 years, first skyrocketed by 138333.33% in 2021, then plummeted by 92857.14% in 2023.
- Over the past 5 years, Avanos Medical's Income towards Parent Company (Quarter) stood at -$49.0 million in 2020, then surged by 47.55% to -$25.7 million in 2021, then skyrocketed by 128.02% to $7.2 million in 2022, then plummeted by 106.94% to -$500000.0 in 2023, then plummeted by 220.0% to -$1.6 million in 2024.
- Its Income towards Parent Company was -$1.6 million in Q3 2024, compared to -$2.5 million in Q2 2024 and -$1.4 million in Q1 2024.